Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026)
Embecta's (EMBC) quarterly Liabilities and Shareholders Equity came in at $1.3 billion in Q2 2026, up 9.33% year-over-year from $1.2 billion in Q2 2025, and up 22.93% quarter-over-quarter from $1.0 billion in Q1 2026.
Powered by 
Analysis
Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Embecta has disclosed Liabilities and Shareholders Equity across 6 years of filings, most recently posting $1.3 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 9.33% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $4.4 billion (down 5.58% YoY), while the FY2025 annual figure was $1.1 billion, down 15.12% from the prior year.
- Liabilities and Shareholders Equity came in at $1.3 billion for Q2 2026 at Embecta, up from $1.0 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.3 billion in Q3 2024 to a low of $833.5 million in Q1 2022.
- Average Liabilities and Shareholders Equity over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2022.
- Year-over-year, Liabilities and Shareholders Equity soared 61.77% in 2022 and retreated 15.12% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $1.2 billion in 2022, then increased by 1.75% to $1.2 billion in 2023, then slipped by 5.61% to $1.1 billion in 2024, then declined by 7.46% to $1.1 billion in 2025, then gained by 18.95% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.3 billion in Q2 2026, $1.0 billion in Q1 2026, and $1.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn | 6.46 Bn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn | 8.97 Bn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn | 31.10 Bn |
| 10 | Embecta | 300.30 Mn | 82.10 Mn | 153.30 Mn | 1.27 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.22 Bn |
| Sep 30, 2023 | 1.21 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.21 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.09 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 833.50 Mn |
| Dec 31, 2021 | 739.90 Mn |
| Sep 30, 2021 | 788.00 Mn |
API Access
Embecta Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EMBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EMBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EMBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();